Format

Send to

Choose Destination
Vaccine. 2009 Jun 2;27(27):3598-604. doi: 10.1016/j.vaccine.2009.03.058. Epub 2009 Apr 9.

A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.

Author information

1
Division of International Medicine and Infectious Diseases, Weill Cornell Medical College, New York, NY, United States. DFGardiner@gmail.com

Abstract

Clostridium difficile is a pathogen with increasing severity for which host antibody responses provide protection from disease. DNA vaccination has several advantages compared to traditional vaccine methods, however no study has examined this platform against C. difficile toxins. A synthetic gene was created encoding the receptor-binding domain (RBD) of C. difficile toxin A, optimized for expression in human cells. Gene expression was examined in vitro. Mice were inoculated and then challenged with parenteral toxin A. Vaccination provided high titer antibodies and protected mice from death. This represents the first report of DNA vaccine inducing neutralizing antibodies to C. difficile toxin A.

PMID:
19464540
PMCID:
PMC2709243
DOI:
10.1016/j.vaccine.2009.03.058
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center